eGFR 59? Kidney Test Results Explained: eGFR, Creatinine & When to Upload (2026)
Summary & Key Takeaway
Your kidney function test results tell a story that most patients never learn to read. Three numbers do most of the work: estimated glomerular filtration rate (eGFR), creatinine, and blood urea nitrogen (BUN). Each value reflects a different aspect of how well your kidneys filter waste, and understanding the relationship between them is the key to interpreting your results. A single abnormal value is rarely a diagnosis; a pattern across values is the language your doctor is reading. This guide walks you through the three core kidney labs, what the stages of chronic kidney disease look like in your numbers, and when your results warrant a specialist visit.
?? Core Insights
- eGFR is the single most important kidney function number. A value above 60 mL/min is normal for most adults; values between 30 and 59 indicate reduced kidney function across three stages of CKD.
- Creatinine is a muscle waste product that your kidneys filter. A high creatinine (above 1.3 mg/dL for women, 1.4 for men) signals reduced kidney filtration, but the absolute number depends on muscle mass, age, and sex.
- BUN (blood urea nitrogen) rises when your kidneys cannot clear urea efficiently, but it also rises with dehydration, high-protein diets, and certain medications. The BUN-to-creatinine ratio helps separate kidney causes from non-kidney causes.
- About 15% of US adults have CKD, but 90% of those with mild-to-moderate disease do not know it because kidney disease is silent until advanced stages.
- Premedice's free AI kidney function review explains your results in plain English and flags when further specialist evaluation is warranted, all with zero data retention.
Why Kidney Function Matters More Than Most Patients Realize
Chronic kidney disease (CKD) affects approximately 15% of US adults, or about 37 million people, according to the CDC. The alarming statistic is that 90% of adults with mild-to-moderate CKD do not know they have it. Kidney disease is silent in its early stages. Blood tests and urine tests are the only way to detect it before significant kidney function is lost.
The kidneys filter approximately 180 liters of blood per day. They regulate blood pressure, produce red blood cells, maintain electrolyte balance, and remove waste products. When kidney function declines, the effects ripple through the entire body. Waste products accumulate, blood pressure rises, anemia develops, and the risk of cardiovascular disease increases substantially. CKD is associated with a 2-3x increase in cardiovascular mortality, which is why early detection matters.
Most patients receive a basic metabolic panel (BMP) or comprehensive metabolic panel (CMP) as part of routine blood work. Both panels include the kidney function markers. The numbers are on your report, but the interpretation is rarely explained. By the time kidney symptoms are obvious (fatigue, swelling, changes in urination), significant function has already been lost. Understanding your numbers before symptoms appear is the difference between prevention and crisis management.
eGFR: The Number That Defines Your Kidney Function
Estimated glomerular filtration rate (eGFR) is the single most important kidney function number on your blood test. It estimates how many milliliters of blood your kidneys filter per minute, normalized to your body size. The standard threshold for normal kidney function in adults is 60 mL/min or above. Values between 30 and 59 indicate reduced kidney function across three stages of CKD. Below 15 signals kidney failure requiring dialysis or transplant evaluation.
The eGFR is calculated from your creatinine, age, sex, and sometimes race. The formula adjusts for the fact that creatinine is produced by muscle, so a muscular person will have a higher creatinine than a sedentary person with the same actual kidney function. The 2021 CKD-EPI equation removed race as a variable, which is important because race-based adjustments were historically inaccurate and contributed to underdiagnosis of kidney disease in Black patients.
The five stages of CKD are defined by eGFR: Stage 1 (eGFR >= 90 with kidney damage markers), Stage 2 (eGFR 60-89 with damage markers), Stage 3a (eGFR 45-59), Stage 3b (eGFR 30-44), Stage 4 (eGFR 15-29), and Stage 5 (eGFR < 15). Most patients with early CKD are in Stage 3a, which often has no symptoms and is detected only through blood tests. Progression from Stage 3 to Stage 4 typically takes years, and progression from Stage 4 to Stage 5 can be delayed or prevented with appropriate management.
Creatinine: The Building Block of eGFR
Creatinine is a waste product produced by muscle metabolism. It is filtered by the kidneys and excreted in urine at a relatively constant rate. The blood creatinine level is the raw input that the eGFR equation uses to estimate kidney function. Normal creatinine ranges from 0.6 to 1.2 mg/dL for women and 0.7 to 1.4 mg/dL for men, but the interpretation depends on the eGFR, not the creatinine alone.
A creatinine of 1.5 mg/dL in a 25-year-old male bodybuilder is a very different finding than a creatinine of 1.5 mg/dL in an 80-year-old woman with low muscle mass. The eGFR adjusts for these differences. If your creatinine is elevated but your eGFR is above 60, the elevation may reflect muscle mass, recent high-intensity exercise, or a high-protein meal. If your creatinine is elevated and your eGFR is below 60, the elevation is more likely to reflect reduced kidney function.
Several factors can affect creatinine independent of kidney function. Recent consumption of cooked meat can raise creatinine by 0.2-0.4 mg/dL for several hours. Creatine supplements, certain medications (trimethoprim, cimetidine, fenofibrate), and dehydration can also elevate creatinine. Drug-induced creatinine elevations are not usually a sign of kidney damage, but they can confuse the interpretation. Repeat testing after a few days without the offending factor clarifies the picture.
BUN and the BUN-to-Creatinine Ratio
Blood urea nitrogen (BUN) measures the amount of urea nitrogen in your blood. Urea is a waste product of protein metabolism that is filtered by the kidneys and excreted in urine. Normal BUN ranges from 7 to 20 mg/dL for adults. BUN rises when the kidneys cannot clear urea efficiently, but it also rises with dehydration, high-protein diets, gastrointestinal bleeding, and certain medications.
The BUN-to-creatinine ratio helps separate kidney causes from non-kidney causes of BUN elevation. A ratio between 10 and 20 is normal. A ratio above 20 with elevated creatinine suggests reduced kidney function. A ratio above 20 with normal creatinine suggests dehydration, high-protein intake, or gastrointestinal bleeding. A ratio below 10 with elevated creatinine suggests liver disease, malnutrition, or severe muscle wasting.
BUN is a less specific marker than creatinine for kidney function because it is influenced by many non-kidney factors. However, it adds useful context when interpreted alongside creatinine. A patient with elevated creatinine and elevated BUN with a normal ratio is more likely to have intrinsic kidney disease. A patient with elevated BUN and normal creatinine with an elevated ratio is more likely to have a non-kidney cause, such as dehydration, which is reversible with fluid intake.
What Causes Reduced Kidney Function
The two leading causes of CKD in the United States are diabetes and high blood pressure, which together account for approximately 70% of cases. Diabetic kidney disease develops in 30-40% of patients with type 1 diabetes and 20-30% of those with type 2 diabetes. Hypertensive kidney disease develops gradually over years of uncontrolled blood pressure. Both conditions damage the small blood vessels in the kidneys, reducing filtration capacity.
Other causes of CKD include glomerulonephritis (inflammation of the kidney filtering units), polycystic kidney disease (genetic condition causing cyst growth), autoimmune diseases (lupus, IgA nephropathy), repeated kidney infections, prolonged obstruction (kidney stones, enlarged prostate), and toxic exposures (NSAIDs, certain antibiotics, contrast dye). Some causes are reversible if caught early (obstruction, certain medications), while others require lifelong management.
Risk factors for CKD include diabetes, high blood pressure, family history of kidney disease, age over 60, obesity, smoking, and cardiovascular disease. African American, Hispanic, and Native American populations have higher rates of CKD, partly due to higher rates of diabetes and hypertension and partly due to historical disparities in healthcare access. The CKD-EPI equation that removed race as a variable was an important step toward more accurate diagnosis across all populations.
The Symptoms of Reduced Kidney Function
Early CKD produces no symptoms. This is the most important fact about kidney disease and the reason blood tests are essential. By the time symptoms appear, significant kidney function has typically been lost. Common symptoms of advanced kidney disease include fatigue and weakness (from anemia), swelling in the legs, ankles, and feet (from fluid retention), shortness of breath (from fluid buildup in the lungs), changes in urination (more or less frequent, foamy urine, dark urine), persistent itching, muscle cramps, nausea, and confusion.
Foamy urine is a particularly important sign that is often overlooked. It indicates protein in the urine (proteinuria), which is a marker of kidney damage. Healthy kidneys filter waste products while keeping proteins in the bloodstream. When the filtering units are damaged, proteins leak into the urine. The protein creates foam when the urine is expelled, similar to the foam created by soap. Any patient with persistent foamy urine should have a urine albumin-to-creatinine ratio test to assess protein loss.
Blood in the urine (hematuria) is another sign that warrants evaluation. It can indicate kidney stones, infection, or kidney disease. Some causes are benign (strenuous exercise, certain medications), but others require treatment. Visible blood in the urine is always a reason to seek medical attention. Microscopic blood, detected on a urine test, may or may not be significant depending on the context. An AI kidney function review can help you understand which findings warrant follow-up.
How Doctors Diagnose and Stage Kidney Disease
The diagnosis of CKD requires evidence of kidney damage or reduced function that persists for at least three months. A single abnormal eGFR value is not enough, because acute illness, dehydration, and medications can temporarily affect kidney function. The diagnosis is confirmed by repeat testing after 3 months showing persistent eGFR below 60 or persistent markers of kidney damage (albuminuria, abnormal imaging, abnormal biopsy).
The additional tests used to stage CKD include a urine albumin-to-creatinine ratio (UACR), which measures protein loss in the urine. A UACR below 30 mg/g is normal. 30-300 indicates moderately increased albuminuria (formerly called microalbuminuria). Above 300 indicates severely increased albuminuria (formerly called macroalbuminuria). The combination of eGFR and UACR is used to classify CKD into categories that guide treatment.
Additional testing may include imaging (ultrasound to assess kidney size and structure), specialized blood tests (electrolytes, phosphate, parathyroid hormone, hemoglobin), and in some cases, a kidney biopsy. The biopsy is reserved for cases where the diagnosis is unclear or where specific treatment depends on the histological subtype. For most patients with diabetes-related or hypertension-related CKD, the diagnosis is made without biopsy.
How to Slow or Prevent Kidney Disease Progression
The most effective interventions for slowing CKD progression are blood pressure control, blood sugar control (for diabetic patients), and the use of ACE inhibitors or ARBs (medications that protect the kidneys). ACE inhibitors and ARBs reduce protein loss in the urine and slow the rate of eGFR decline. They are recommended for all CKD patients with albuminuria, regardless of blood pressure.
Lifestyle modifications include reducing sodium intake (less than 2,300 mg per day), limiting protein intake (especially in advanced CKD), maintaining a healthy weight, exercising regularly, quitting smoking, and limiting alcohol. These interventions are most effective when started early. Patients who receive a CKD diagnosis at Stage 3a and implement these changes can often delay progression to more advanced stages by years or even decades.
Newer medications have expanded the treatment options for CKD. SGLT2 inhibitors (originally developed for diabetes) have been shown to slow CKD progression in patients with and without diabetes. GLP-1 receptor agonists (originally developed for diabetes and weight loss) have shown promise for kidney protection. Finerenone, a non-steroidal mineralocorticoid receptor antagonist, has also shown kidney-protective effects in patients with diabetic kidney disease. These new medications are changing the landscape of CKD management.
When to See a Nephrologist (Kidney Specialist)
Most patients with early CKD can be managed by their primary care physician. Referral to a nephrologist is typically recommended for Stage 4 CKD (eGFR below 30), rapidly declining kidney function (eGFR decline of more than 5 mL/min per year), persistent albuminuria despite treatment, complex causes of CKD, or advanced disease requiring preparation for dialysis or transplant.
Patients who benefit from early nephrology referral include those with advanced CKD at diagnosis, those with diabetes and significant albuminuria, those with family history of polycystic kidney disease, and those with CKD and recurrent kidney stones. Earlier referral is associated with better outcomes, including slower CKD progression, lower cardiovascular mortality, and better preparation for renal replacement therapy when needed.
For patients who want to understand their kidney function results before seeing a specialist, an AI kidney function review can provide a structured summary in plain English. The AI identifies the patterns that suggest reduced kidney function, classifies the results by CKD stage when appropriate, and flags findings that warrant specialist evaluation. The review is free, takes under a minute, and leaves no data retention.
Dr. Elena Rostova, MD, PhD
Dr. Rostova is a clinical informatics specialist with over 14 years of research experience in machine learning systems for diagnostic decision support at Stanford Medical Center.
Expert Takeaway
Kidney function is one of the most important things your blood tests can tell you, and it is one of the most overlooked. A mild eGFR drop that is monitored and addressed early can prevent progression to dialysis. A value that is ignored for years cannot.
QFrequently Asked Questions
Q1What is a normal eGFR value?
A normal eGFR is 60 mL/min or above. Values between 60 and 90 are normal for many adults but may indicate Stage 1 or 2 CKD if there are other signs of kidney damage (proteinuria, abnormal imaging). Values between 30 and 59 indicate Stage 3 CKD. Below 30 indicates Stage 4 or 5 CKD, which requires specialist management. Most patients with eGFR above 90 have normal kidney function.
Q2What does a high creatinine mean?
A high creatinine (above 1.3 mg/dL for women, 1.4 for men) usually indicates reduced kidney filtration, but can also reflect high muscle mass, recent high-intensity exercise, a high-protein meal, creatine supplements, or certain medications. The eGFR calculation accounts for muscle mass and age, so the eGFR is a more accurate measure of kidney function than creatinine alone.
Q3What is the BUN to creatinine ratio test?
The BUN-to-creatinine ratio compares the two kidney markers to help separate kidney causes from non-kidney causes of BUN elevation. A ratio between 10 and 20 is normal. A ratio above 20 with elevated creatinine suggests kidney disease. A ratio above 20 with normal creatinine suggests dehydration, high-protein intake, or gastrointestinal bleeding. A ratio below 10 with elevated creatinine suggests liver disease or malnutrition.
Q4Can kidney function improve?
Kidney function can improve in early CKD through blood pressure control, blood sugar control, ACE inhibitors or ARBs, and lifestyle modifications. Acute kidney injury (sudden kidney damage from dehydration, medications, or infection) can recover fully with treatment. However, chronic kidney disease that has progressed to Stage 3b or beyond typically cannot be fully reversed, though progression can be slowed significantly.
Q5How often should I get my kidney function tested?
Healthy adults should have kidney function tested every 1-3 years as part of routine blood work. Patients with diabetes, high blood pressure, or family history of kidney disease should be tested annually. Patients with known CKD should be tested every 3-6 months, with more frequent monitoring in advanced stages. Your doctor will determine the appropriate testing frequency based on your risk factors and current kidney function.
Q6What are the signs of kidney problems?
Early kidney disease has no symptoms. As kidney function declines, symptoms include fatigue, swelling in the legs and ankles, shortness of breath, changes in urination, foamy urine, blood in the urine, persistent itching, muscle cramps, and nausea. The absence of symptoms does not mean the kidneys are healthy. Blood tests and urine tests are the only way to detect early kidney disease.
Verified References & Literature
KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of CKD
Kidney International, 2024
View SourceSGLT2 Inhibitors in CKD: Cardiovascular and Renal Outcomes
New England Journal of Medicine, 2023
View SourceGet a structured second read in seconds
Upload lab results, describe symptoms, or ask about a diagnosis — Premedice gives you medically-grounded answers backed by 30+ clinical databases.
